The USNA Q1'13 earnings are scheduled to be declared a few hours from now. The strength of the stock has continued and it has risen by more than 63% over the last few months. It had made its low of $30.51 in December, and the 52 week high at $50.23 is very close now. It is trading well above its 50 DMA ($47.27) and the 200 DMA of $42.77. The strength, however, is not totally supported by volumes. The 3 month average is 184K shares compared with the 10 day average of 74K. Fundamentally, the trailing P/E just above 11 and the forward P/E is 8.69 indicating expectation of earnings growth. The low PEG of 0.52 also points to this fact. The price to sales is only 1.01 and hence, despite the recent uptrend, the stock is still available at decent valuations. There is no debt on books and the book value per share is $13.43. On a sequential basis, the revenues & net income did not show much growth in Q4'12 but on a more comparable YoY basis, the growth was 15% and 40% respectively for revenue and net income. For the positive trend to continue, there has to be some improvement on this front. Q1'13 results will determine the short term future of the stock but the long term success depends on the type of products it is able to offer to its consumers. Various segments of the nutritional supplements market are highly active and new products are coming out all the time. MusclePharm (MSLP) recently brought out FitMiss for a specific segment of the market. MSLP also expanded margins in the recently declared results. It is one great story where growth has been phenomenal ($1 million to $78 million in 4 years). USNA needs to tap into the growth opportunities in various segments of the market and also develop / acquire new products to push the growth story. Let us hear what the management has to say.